Celostatin LAR (Octreotide) Injection
Generic API Name: Octreotide. Generic Branded Name: Celostatin LAR is available in India. It is used to reduce flushing episodes and watery diarrhea caused by cancerous tumors (carcinoid syndrome) or tumors called vasoactive intestinal peptide tumors (VIPomas). Octreotide injection is used to treat severe diarrhea and other symptoms that occur with certain intestinal tumors (eg, vasoactive intestinal peptide tumors or VIPomas) or metastatic carcinoid tumors (tumors that has already spread in the body). It does not cure the tumor but it helps the patient feel more comfortable. Generic brands for Octreotide Acetate Injection Available in India Brand Name Celostatin Lar Generic Name Octreotide Acetate Injection Strength 100 mcg/ml Manufacturer Celon Laboratories Ltd Aark ,a licensed pharmaceu
About Celostatin LAR (Octreotide) Injection
Description Octreotide, sold under the brand name Celostatin LAR, It is licensed for the treatment of acute myeloid leukemia (AML) . Tumors- Octreotide is used for the treatment of growth hormone producing tumors (acromegaly and gigantism). Octreotide is also used in mild cases of glucagonoma when surgery is not an option. Bleeding esophageal varices – Octreotide is often given as an infusion for management of acute hemorrhage from esophageal varices in liver cirrhosis. Radiolabeling – Octreotide is used in nuclear medicine imaging by labeling with indium-111 (Octreoscan) to noninvasively image neuroendocrine and other tumours expressing somatostatin receptors. Acromegaly – In June 2020, octreotide (Mycapssa) was approved for medical use in the United States with an indication for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. Hypoglycemia – Octreotide is also used in the treatment of refractory hypoglycemia or congenital hyperinsulinism in neonates and sulphonylurea-induced hypoglycemia in adults. It was approved for use in the United States in 1988. Octreotide was approved for medical use in the European Union in 2022. As of June 2020, octreotide is the first oral somatostatin analog (SSA) approved by the FDA. List of available brand-name drugs in India for Octreotide Injection Branded Generic Drugs for Octreotide Injection : Bdocterio (Octreotide) For Injection | Celostatin LAR (Octreotide) | Ferotide (Octreotide) | Octri (Octreotide) Injection | Octride (Octreotide) Injection | Sandostatin (Octreotide) | Celostatin (Octreotide) NEWS / Updates Hospira U.K. Limited, Electronic Medicines Compendium (EMC), [Revised on May 2022] [Accessed on 16th Aug 2022], https://www.medicines.org.uk/emc/files/pil.375.pdf Novartis pharmaceuticals corporation, U.S. Food and Drug Administration, [Revised on 2002] [Accessed on 16th Aug 2022], Written By Mr. Sandeep Tomar (D. pharma) Last updated 26 Sep 2024 | 05:03 AM (IST)
